Myocardial Infarction is the leading cause of death and disability worldwide. It has been reported that GCN-5 inhibitors inhibit GCN-5 mediated acetylation of PGC-1 alpha, which in turns enhances PGC-1alpha activity, mitochondrial function and oxidative metabolism. PGC-1α activity is regulated by Histone deacetylases and Histone acetyl transferases. In particularly PGC-1α is directly acetylated by HAT enzyme-general control non derepressible 5 (GCN-5). Ethyl-2-methylquinoline-3-carboxylate is reported to be a specific inhibitor of GCN-5. PGC-1 α levels are reported to be reduced in heart following myocardial infarction and up regulation of PGC-1 α confers protection against ischaemia and reperfusion in cardiomyoblast cells. Thus, in present study we investigated the protective effect of Ethyl-2-methyl quinoline-3-carboxylate as GCN-5 inhibitor in modulation of PGC-1 alpha activity during ischemia and reperfusion induced myocardial injury.
INTRODUCTION
Myocardial Infarction is the leading cause of death and disability worldwide. Early reperfusion with thrombolysis or percutaneous trans-luminal coronary angioplasty is necessary to restore blood supply and salvage ischemic myocardium. However, Reperfusion paradoxically results in oxidative stress, the loss of membrane phospholipids and Ca 2+ overload leading to further cardiomyocyte death-termed as "Reperfusion injury". A short and less severe ischaemia followed by reperfusion produces reversible injury manifested as contractile dysfunction (Kim et al., 2003) ,endothelial and vascular dysfunction leading to "impaired blood flow" and arrhythmias, whereas prolonged severe ischaemia followed by reperfusion produce irreversible cell death termed as lethal reperfusion injury (Yellon and Hausenloy, 2007) . In the adult heart, fatty acid oxidation and expression of mitochondrial genes for oxidative phosphorylation is regulated by the transcriptional coactivator, peroxisome proliferator-activated receptorcoactivator-1α (PGC-1 α), which is abundantly expressed in heart (Witt H et al., 2008) . However, in response to pathological stressors such as hemodynamic load or ischemia, cardiac myocytes down-regulate PGC-1 alpha level and fatty acid oxidation genes in preference for glucose metabolism pathways (Rosano et al., 2008) . The genetic deletion of PGC-1α results in diminished cardiac mitochondrial enzyme activities, diminished ATP production, blunted cardiac postnatal growth, diminished chronotropic capacity and an inability to appropriately augment cardiac workload in response to exercise or to β-adrenergic stimulation (Arany et al., 2005 and Leone et al., 2005) . In failing heart, synthesis of ATP is compromised as a result of mitochondrial dysfunction (Mudd and Kass, 2008) . Chronic administration of low dose of metformin affords cardio protection against ischemia-induced heart failure by improving mitochondrial function via activation of AMPK and its downstream signaling pathway involving PGC-1α and eNOS (Gundewar et al., 2009 ). In delayed cardiac ischemic preconditioning PGC-1α is temporarily induced during the transient ischemic stress which is then associated with subsequent enhanced myocardial ischemia-reperfusion tolerance ( It has been reported that GCN-5 inhibitors inhibit GCN-5 mediated acetylation of PGC-1 alpha, which in turns enhances PGC-1alpha activity, mitochondrial function and oxidative metabolism. Ethyl-2-methylquinoline-3-carboxylate is reported to be a specific inhibitor of GCN-5 (Mai et al., 2005) . It exerted inhibition on catalytic activity of GCN-5 and showed inhibition of mutant yeast strains. PGC-1 α levels are reported to be reduced in heart following myocardial infarction (Sun et al., 2007) and upregulation of PGC-1 α confers protection against ischaemia and reperfusion in cardiomyoblast cells (Sun et al., 2013) . Thus, in present study we investigated the protective effect of Ethyl-2-methyl quinoline-3-carboxylate as GCN-5 inhibitor in modulation of PGC 1 alpha activity during ischemia and reperfusion induced myocardial injury.
MATERIALS AND METHODS
Wistar rats of either sex, weighing 200-250 gm, were used in the present study. They were housed in the Animal House in group of three in polypropylene cages with husk bedding under standard conditions of light and dark cycle with food and water ad libitium. Animals were acclimatized to laboratory conditions before the test.
Isolated Rat Heart Preparation
Rats were heparinised (500 I.U, i.p.) and sacrificed by cervical dislocation. Hearts were rapidly excised and immediately mounted on Langendorffs apparatus (Langendorffs, 1895). The heart was enclosed in a double walled jacket and the temperature of which was maintained at 37 0 C by circulating hot water. The preparation was perfused with Krebs Heinseleit (K-H) solution (NaCl 118mM; KCl 4.7mM; CaCl 2 2.5mM; MgSO 4 .7H 2 O 1.2mM; NaHCO 3 25mM; KH 2 PO 4 1.2mM and C 6 H 12 O 6 11mM) pH 7.4, maintained at 37 0 C and bubbled with 95% O 2 and 5% CO 2 . The coronary flow rate was maintained 6-9ml/ min and perfusion pressure was kept constant at 70 mm Hg. Global ischaemia was produced for 30 min by closing the inflow of physiological solution and it was followed by reperfusion for 120 min. Four ECG electrodes fixed at the ventricles and auricles were employed to record ECG (Physiograph, INCO, India) for monitoring heart rate.
Infarct Size Measurement
Heart was removed from Langendroff"s apparatus. Both the auricles, the root of aorta and right ventricle were excised and left ventricle was kept overnight at 4°C. Frozen ventricle was sliced into uniform sections of 2-3 mm thickness. The slices were incubated in 1% tripheny 1 tetrazolium (TTC) solution in 0.1M Tris buffer pH 7.8, for 20 min at 37°C. Dehydrogenase enzyme and cofactor NADH present in the viable myocardium react with tetrazolium salt to form a formazon pigment, which is intensely coloured brick red. The enzyme and cofactor were lost from the infarcted cardiac cells. Thus infarcted portion remains unstained while the viable myocardium was stained brick red with TTC. Infarct size was measured by macroscopic methods i.e. volume method.
Volume Method
Ventricular slices were placed between two glass slides and a transparent plastic grid with 100 squares in 1cm 2 was placed over it. Average area of each ventricular slice was calculated by counting the number of squares on either side. Similarly numbers of squares falling on stained and unstained area were counted on both sides. Non-stained dull yellow area represented the infracted portion and red area represented the viable portion. Infarct size was expressed as percentage of total left ventricular volume (%LVV).
Estimation of Lactate Dehydrogenase (LDH)
LDH was estimated in coronary effluent by 2, 4-DNPH method (King. 1959 ).
Principal LDH catalyses the following reaction:
Lactate + NAD Pyruvate + NADH
The pyruvate so formed is coupled with 2, 4-dinitrophenylhydrazine (2, 4-DNPH) to give correspondence hydrazone which gives a brown colour in alkaline medium. The intensity of this colour is proportional to the amount of LDH activity and is measured spectrophotometrically at 440nm.
Estimation of Creatine Phosphokinase (CK)
CK was measured in the coronary effluent by modified method of Hughes, 1961. Principal CK catalyzes the following reaction: Creatine phosphate + ADP Creatine + ATP At pH 7.4, CK catalyses the forward reaction. The creatine so formed, reacts with diacetyl and α -naphthol in alkaline medium to give pink coloured complex. The intensity of this colour is proportional to enzyme activity and is measured spectrophotometrically at 520 nm. Mg 2+ and cysteine were added as a activators. P-choloromercuribenzoate stops the reaction by inactivating the enzyme.
RESULTS AND DISCUSSION

Effect of Ethyl-2-Methylquinoline-3-Carboxylateon Haemodynamic Responses
Global ischaemia followed by reperfusion for 120 min. significantly reduced heart rate (217.2±3.07 to 62±5.254) and coronary flow rate (8.02±.2653 to 2.12±.332). Ethyl-2-methylquinoline-3-carboxylate (0.5mM and 1.0 mM) treatment before global ischaemia significantly improves the heart rate and coronary flow rate (Table 7,8) .
Effect of Ethyl-2-Methylquinoline-3-Carboxylateon Ischaemia-Reperfusion Induced Myocardial Infarct Size
Global ischaemia for 30 min followed by reperfusion for 120 min produced significant increase in myocardial infarct size calculated by volume method. Treatment with ethyl-2-methylquinoline-3-carboxylate (0.5mM and 1.0 mM), a GCN-5 inhibitor, before global ischaemia significantly reduced myocardial infarct size. Moreover, there was greater decrease in infarct size at 1.0 mM dose as compared to 0.5 mM. (Fig. 48a, 48b ).
Effect of Ethyl-2-Methylquinoline-3-Carboxylate on Ischaemia-Reperfusion Induced Ldh and Ck Release
Global ischaemia for 30 min followed by reperfusion for 120 min significantly increased the release of LDH in coronary effluent noted immediately, 30 min and 120 min after reperfusion. Similarly, there was a significant increase in release of CK noted 5 min after reperfusion. Ethyl-2-methylquinoline-3-carboxylate (0.5mM and 1.0 mM) treatment before global ischaemia significantly attenuated the ischaemia-reperfusion induced release of LDH and CK release at 120mM, dose dependently. Ethyl-2-methylquinoline-3-carboxylate (0.5mM and 1.0 mM) before global ischaemia result in similar decrease in CK level at 0 min RP. 
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